New Division At Danish Medicines Agency To Put Greater Focus On Benefit-Risk Issues
Executive Summary
Major organizational changes are in store for the Danish Medicines Agency in the New Year that will aim to modernize its processes and functioning.
You may also be interested in...
Danish Pharma Hopes Stand-alone Medicines Agency Will Speed Up Drug Reviews
Pharma group hopes DMA will clear up drug review backlog once it is separated from larger health authority.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.